(Editor’s Note: this is Part 1 of the new 3‑part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.)
On average, the medications prescribed for brain-related conditions benefit approximately 50% of patients. But which 50%?
Personalized Medicine seeks to move away from the current “1 size fits all, trial and error” approach that has been necessary because of a lack of evidence. Instead, it focuses on [Read more…] about The State of Personalized Medicine: The Role of Biomarkers